Dan Engelhard
About
In The Last Decade
Dan Engelhard
167 papers receiving 7.1k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Epidemiology 3.8k
- Oncology 2.4k
- Infectious Diseases 2.2k
- Hematology 1.2k
- Immunology 1.1k
Countries citing papers authored by Dan Engelhard
This map shows the geographic impact of Dan Engelhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Engelhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Engelhard more than expected).
Fields of papers citing papers by Dan Engelhard
This network shows the impact of papers produced by Dan Engelhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Engelhard. The network helps show where Dan Engelhard may publish in the future.
Co-authorship network of co-authors of Dan Engelhard
This figure shows the co-authorship network connecting the top 25 collaborators of Dan Engelhard. A scholar is included among the top collaborators of Dan Engelhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Engelhard. Dan Engelhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 238 | |
| 3 | 26 | |
| 4 | 9 | |
| 5 | European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia breakdown → | 408 |
| 6 | 83 | |
| 7 | 204 | |
| 8 | 24 | |
| 9 | 16 | |
| 10 | Definitions of infectious diseases and complications after stem cell transplant | 9 |
| 11 | 47 | |
| 12 | Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation. | 63 |
| 13 | Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party. | 39 |
| 14 | Cefuroxime efficacy in pneumonia: sequential short-course i.v./oral suspension therapy. | 21 |
| 15 | ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES | 3 |
| 16 | 16 | |
| 17 | Epidemiological observations in the AIDS clinic at the Hadassah University Hospital in Jerusalem. | 1 |
| 18 | Combined therapy with granulocyte transfusion, intravenous opsonins and antibiotics for overwhelming Pseudomonas aeruginosa septicemia in neutropenic cancer patients. | 3 |
| 19 | 14 | |
| 20 | Review on Efficacy and Complications of Granulocyte Transfusions in Neutropenic Patients: EBMT Educational Meeting from the Severe Aplastic Anaemia and Infectious Diseases Working Parties, Naples, Italy, 2014 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.